Search for the latest updates on diabetes
News
Boston Therapeutics Initiates Phase IIb Study to Assess the Efficacy and Safety of SUGARDOWN(R) for Type 2 Diabetes Marketwired via Yahoo! Finance - 11 minutes
MANCHESTER, NH--(Marketwired - May 29, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a leading developer of compounds that address ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment